Lynch J - Search Results

1

From Burnout to Resilience: An Update for Oncologists.

Murali K, Makker V, Lynch J, Banerjee S. Murali K, et al. Among authors: lynch j. Am Soc Clin Oncol Educ Book. 2018 May 23;38:862-872. doi: 10.1200/EDBK_201023. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231394 Free article. Review.

2

The Man in the Vest.

Lynch JW. Lynch JW. J Clin Oncol. 2017 Dec 10;35(35):3987-3988. doi: 10.1200/JCO.2017.75.1321. Epub 2017 Oct 6. J Clin Oncol. 2017. PMID: 28985101 No abstract available.

3

Stevens-Johnson syndrome resulting from whole-brain radiation and phenytoin.

Cockey GH, Amann ST, Reents SB, Lynch JW Jr. Cockey GH, et al. Among authors: lynch jw jr. Am J Clin Oncol. 1996 Feb;19(1):32-4. doi: 10.1097/00000421-199602000-00007. Am J Clin Oncol. 1996. PMID: 8554032

4

Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida.

Chera BS, Olivier K, Morris CG, Lynch JW, Mendenhall NP. Chera BS, et al. Am J Clin Oncol. 2007 Dec;30(6):601-6. doi: 10.1097/COC.0b013e318145b9db. Am J Clin Oncol. 2007. PMID: 18091054

5

Phase II study of fludarabine combined with interferon-alpha-2a followed by maintenance therapy with interferon-alpha-2a in patients with low-grade non-hodgkin's lymphoma.

Lynch JW, Hei DL, Braylan RC, Rimzsa LM, Staab EV, Bewsher CJ, Mendenhall NP, Hudson JK. Lynch JW, et al. Am J Clin Oncol. 2002 Aug;25(4):391-7. doi: 10.1097/00000421-200208000-00015. Am J Clin Oncol. 2002. PMID: 12151972 Clinical Trial.

6

Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adults.

Patel SJ, Lynch JW Jr, Johnson T, Carroll RR, Schumacher C, Spanier S, Scarborough M. Patel SJ, et al. Among authors: lynch jw jr. Am J Clin Oncol. 2002 Oct;25(5):489-95. doi: 10.1097/00000421-200210000-00014. Am J Clin Oncol. 2002. PMID: 12393991 Clinical Trial.

7

Phase II trial of individualized rituximab dosing for patients with CD20-positive lymphoproliferative disorders.

Gordan LN, Grow WB, Pusateri A, Douglas V, Mendenhall NP, Lynch JW. Gordan LN, et al. J Clin Oncol. 2005 Feb 20;23(6):1096-102. doi: 10.1200/JCO.2005.12.171. Epub 2005 Jan 18. J Clin Oncol. 2005. PMID: 15657402 Clinical Trial.

8

The role of prognostic factors in treatment selection for early-stage Hodgkin's disease.

Mendenhall NP, Cantor AB, Barré DM, Lynch JW Jr, Million RR. Mendenhall NP, et al. Among authors: lynch jw jr. Am J Clin Oncol. 1994 Jun;17(3):189-95. doi: 10.1097/00000421-199406000-00002. Am J Clin Oncol. 1994. PMID: 8192101

9

A phase II study of gemcitabine in patients with relapsed or refractory low-grade non-Hodgkin lymphoma.

Larson BJ, Waples JM, Pusateri A, Mendenhall NP, Lynch JW Jr. Larson BJ, et al. Among authors: lynch jw jr. Am J Clin Oncol. 2005 Apr;28(2):165-8. doi: 10.1097/01.coc.0000143015.66143.22. Am J Clin Oncol. 2005. PMID: 15803011 Clinical Trial.

10

Lethal midline granuloma-nasal natural killer/T-cell lymphoma.

Mendenhall WM, Olivier KR, Lynch JW Jr, Mendenhall NP. Mendenhall WM, et al. Am J Clin Oncol. 2006 Apr;29(2):202-6. doi: 10.1097/01.coc.0000198738.61238.eb. Am J Clin Oncol. 2006. PMID: 16601443 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,668 results

Search Page